| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |